Assenagon Asset Management S.A. Repligen Corp Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$120.0 - $182.95 $3.27 Million - $4.99 Million	27,280 Added 937.78%	30,189 $3.81 Million
Q1 2024 Apr 24, 2024	SELL	$170.78 - $208.42 $12,466 - $15,214	-73 Reduced 2.45%	2,909 $535,000
Q4 2023 Jan 17, 2024	BUY	$114.17 - $185.35 $5,594 - $9,082	49 Added 1.67%	2,982 $536,000
Q3 2023 Nov 06, 2023	SELL	$138.78 - $176.51 $2,636 - $3,353	-19 Reduced 0.64%	2,933 $466,000
Q2 2023 Jul 25, 2023	SELL	$138.42 - $180.31 $8,305 - $10,818	-60 Reduced 1.99%	2,952 $417,000
Q1 2023 Apr 18, 2023	SELL	$154.26 - $198.1 $28,075 - $36,054	-182 Reduced 5.7%	3,012 $507,000
Q4 2022 Jan 12, 2023	BUY	$162.42 - $220.56 $112,719 - $153,068	694 Added 27.76%	3,194 $541,000
Q3 2022 Oct 27, 2022	BUY	$160.42 - $256.21 $18,127 - $28,951	113 Added 4.73%	2,500 $468,000
Q2 2022 Jul 27, 2022	SELL	$140.68 - $188.02 $6.54 Million - $8.73 Million	-46,455 Reduced 95.11%	2,387 $388,000
Q1 2022 Apr 25, 2022	BUY	$161.19 - $257.96 $6.66 Million - $10.7 Million	41,343 Added 551.31%	48,842 $9.19 Million
Q4 2021 Feb 01, 2022	BUY	$247.59 - $304.47 $1.56 Million - $1.92 Million	6,301 Added 525.96%	7,499 $1.99 Million
Q3 2021 Oct 19, 2021	SELL	$194.77 - $324.21 $7.96 Million - $13.3 Million	-40,879 Reduced 97.15%	1,198 $346,000
Q2 2021 Jul 15, 2021	SELL	$165.87 - $220.95 $1.38 Million - $1.84 Million	-8,312 Reduced 16.5%	42,077 $8.4 Million
Q1 2021 Apr 26, 2021	BUY	$180.37 - $226.26 $3.33 Million - $4.18 Million	18,486 Added 57.94%	50,389 $9.8 Million
Q4 2020 Feb 01, 2021	BUY	$148.08 - $206.57 $2.78 Million - $3.88 Million	18,760 Added 142.74%	31,903 $6.11 Million
Q3 2020 Oct 07, 2020	BUY	$122.51 - $158.27 $1.61 Million - $2.08 Million	13,143 New	13,143 $1.94 Million
Q1 2020 Apr 17, 2020	SELL	$84.96 - $109.14 $1.08 Million - $1.39 Million	-12,741 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$73.84 - $93.08 $940,795 - $1.19 Million	12,741 New	12,741 $1.18 Million
Q1 2018 Apr 30, 2018	SELL	$30.92 - $37.27 $624,584 - $752,854	-20,200 Closed	0 $0
Q4 2017 Jan 25, 2018	SELL	$32.53 - $38.92 $1.86 Million - $2.22 Million	-57,160 Reduced 73.89%	20,200 $733,000
Q3 2017 Oct 18, 2017	BUY	$36.98 - $46.06 $2.86 Million - $3.56 Million	77,360	77,360 $2.96 Million

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$1.17 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$990 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$781 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$251 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$220 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account